Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Histiocytic Neoplasms × ulixertinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Wilms Tumor 2 Sarcoma, Ewing 2 Sarcoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Glioma 2 Ependymoma 2 Xanthogranuloma, Juvenile 1 Uveal Melanoma 1 Neoplasms 1 Histiocytic Sarcoma 1 Histiocytic Neoplasms 1 Gastrointestinal Neoplasms 1 Central Nervous System Neoplasms 1 Advanced Solid Tumor 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06411821 2025-12-15

Ulixertinib in People With Histiocytic Neoplasms

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting

Histiocytic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡